2016-11-12T16-43-05Z
Source: Journal of Behavioral Health
Xin Wang, Hua Chen, Ekere James Essien, Mo Yang, Susan Abughsoh.
This study evaluated prescribing rate of each type of smoking cessation medication and identified predictors of a successful cessation outcome among adult smokers newly prescribed each type of smoking cessation medication. The results showed that varenicline was the most commonly prescribed smoking cessation medication followed by NRT then bupropion. The different types of cessation medication may be particularly beneficial to certain sub-populations in real world.
http://ift.tt/2esEsMt
Σάββατο 12 Νοεμβρίου 2016
Predictors of a Successful Outcome among Adult Smokers using Smoking Cessation Medication
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Objective Outpatient parenteral antimicrobial therapy (OPAT) provides opportunities for improved cost savings, but in the UK, implementation...
-
Abstract Purpose Overcoming the flaws of current data management conditions in head and neck oncology could enable integrated informatio...
-
http://orl-agios.blogspot.com/2017/06/the-preclinical-anticancer-effect-of.html Flavonoids present in foods were considered non-absorbable b...
-
Abstract Ocean acidification increases the amount of dissolved inorganic carbon (DIC) available in seawater which can benefit photosynthes...
-
Vol.31 No.5 from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1k8FKtW via IFTTT
-
Universal newborn hearing screening (UNHS) has become the standard of care in many countries. The aim of this study was to evaluate the resu...
-
Publication date: Available online 24 December 2017 Source: European Journal of Radiology Author(s): Wenbin Jiang, Hongwei Xue, Qinqin W...
-
Geographic region: Does it matter in cutaneous melanoma of the head and neck? Laryngoscope. 2017 Jun 05;: Authors: Kılıç S, Unsal AA,...
-
The overall objective of the guideline is to provide up-to-date, evidence-based recommendations for the management of lichen sclerosus (LS)...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου